{"disease":{"id":"vitreous-opacities","name":"vitreous opacities"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06097897","title":"Imaging of Vitreous Opacities in Human Eyes","phase":"NA","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"PulseMedica","has_results":false},{"nct_id":"NCT06204848","title":"Imaging of Vitreous Opacities in a Canadian Population","phase":"NA","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"PulseMedica","has_results":false},{"nct_id":"NCT07140692","title":"EFFECTIVENESS AND SAFETY ASSESSMENT OF THE VISTA VITRECTOMY PROBE","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"The Eye Centers of Racine and Kenosha","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}